发布文献求助

豆芽

Lv51

1220 积分 2022-06-21 加入

最近求助
最近应助
互助留言

In vivo chimeric antigen receptor (CAR)-T cell therapy 36分钟前 已完结
Humanized Mice for the Study of Immuno-Oncology 1个月前 已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease 1个月前 已完结
CD58 loss was strongly associated with inferior complete response rates and shorter progression-free survival in axi-cel–treated DLBCL patients 2个月前 已关闭
Among non-responders to CD19 CAR T therapy, a notable proportion showed CD58 deletions or reduced expression, suggesting a mechanism of primary resistance 2个月前 已关闭
Tumor CD58 status was shown to be predictive of CAR T-cell synapse quality and killing capacity 2个月前 已关闭
In vivo CAR T cell generation to treat cancer and autoimmune disease 2个月前 已完结
Association of anti-tumor activity in neuroblastoma patient-derived xenografts with levels of GD2 expression 3个月前 已关闭
Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study 3个月前 已完结
Advancements in neuroblastoma treatment: FDA-approved drugs and role of phytochemicals 4个月前 已完结

没有进行任何应助

最近帖子
最近评论

没有发布任何帖子

没有发布任何评论

Copyright © 2020-2025 AbleSci.COM, 科研通, All Right Reserved

科研通是非营利科研互助平台，不忘初心，为科研助力

本站互助的所有文件仅供个人学习研究用，禁止任何人把求助的所得文献进行盈利或传播

皖ICP备2024041134号-1

皖公网安备34019202002308

科研通【文献互助QQ群】：如果您有特殊求助，或发布求助超过24小时未得到应助，可加群求助，群号：941272744【点击一键加群】

科研通【志愿服务QQ群】：如果您热爱文献互助，有热心愿意为更多人服务，请加入小伙伴群，点击申请加入

关注微信服务号

科研通